• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

    7/17/24 6:03:31 AM ET
    $ADVM
    $APVO
    $ASML
    $ASST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    Shares of Bloom Energy Corporation (NYSE:BE) rose sharply in today's pre-market trading after the company announced a strategic partnership with CoreWeave.

    Bloom Energy said it entered into a partnership to deploy its proprietary fuel cells to generate on-site power for CoreWeave at a high-performance data center in Illinois.

    Bloom Energy shares jumped 12.1% to $16.90 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Shimmick Corporation (NASDAQ:SHIM) gained 53% to $3.09 in pre-market trading after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares rose 39.3% to $0.46 in pre-market trading after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.
    • MicroAlgo Inc. (NASDAQ:MLGO) shares rose 26.1% to $3.58 in pre-market trading after declining around 14% on Tuesday.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) rose 16.1% to $0.2916 in pre-market trading. Conduit Pharmaceuticals shares gained around 5% on Tuesday after the company announced it received patent approval for its lead asset targeting autoimmune diseases..
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares gained 15.5% to $10.31 in pre-market trading. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.
    • GitLab Inc. (NASDAQ:GTLB) gained 13.9% to $57.71 in pre-market trading after Reuters reported that the company is exploring a sale.
    • Asset Entities Inc. (NASDAQ:ASST) shares climbed 12.6% to $1.77 in pre-market trading.
    • Immersion Corporation (NASDAQ:IMMR) shares surged 12.4% to $13.69 in pre-market trading after gaining over 5% on Tuesday.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares gained 7.7% to $0.21 in pre-market trading.

    Losers

    • Cineverse Corp (NASDAQ:CNVS) shares fell 15.6% to $0.75 in pre-market trading.
    • Logistic Properties of the Americas (NYSE:LPA) shares fell 15.2% to $22.04 in pre-market trading after jumping 69% on Tuesday.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 15.2% to $1.28 in pre-market trading after jumping 41% on Tuesday.
    • Five Below, Inc. (NASDAQ:FIVE) shares declined 14.7% to $87.00 in pre-market trading after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.
    • Safe and Green Development Corporation (NASDAQ:SGD) shares dipped 11% to $0.3642 in pre-market trading.
    • Silo Pharma, Inc. (NASDAQ:SILO) shares fell 9.2% to $2.17 in pre-market trading. Silo Pharma shares jumped 123% on Tuesday after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer’s drug.
    • Eightco Holdings Inc. (NASDAQ:OCTO) shares fell 8.7% to $0.48 in pre-market trading. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.
    • Cerus Corporation (NASDAQ:CERS) fell 8.4% to $2.19 in pre-market trading. On July 2, Cerus announced the appointment of Dean Gregory to its Board of Directors.
    • Siebert Financial Corp. (NASDAQ:SIEB) fell 6.8% to $1.77 in pre-market trading after gaining over 9% on Tuesday.
    • ASML Holding N.V.  (NASDAQ:ASML) shares declined 6.8% to $995.90 in pre-market trading. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.

    Now Read This:

    • Jim Cramer Says If You Sell This Chinese EV Stock Now, ‘Some Clown’ Will Be ‘Real Positive About It,’ Wait Until ‘All That Stuff Happens’
    Get the next $ADVM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $APVO
    $ASML
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    Bloom Energy Corporation
    $BE
    10/29/2025$150.00Hold → Buy
    HSBC Securities
    Bloom Energy Corporation
    $BE
    10/29/2025$65.00 → $105.00Hold
    TD Cowen
    Five Below Inc.
    $FIVE
    10/27/2025$186.00Neutral → Overweight
    Analyst
    Bloom Energy Corporation
    $BE
    10/9/2025$100.00Buy → Hold
    HSBC Securities
    Bloom Energy Corporation
    $BE
    10/7/2025$100.00Outperform
    Evercore ISI
    GitLab Inc.
    $GTLB
    10/7/2025$52.00Outperform → Neutral
    Mizuho
    ASML Holding N.V. New York Registry Shares
    $ASML
    10/6/2025Buy → Neutral
    New Street
    Bloom Energy Corporation
    $BE
    10/2/2025$79.00Outperform → Neutral
    Mizuho
    More analyst ratings

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO O'Donnell Kevin J bought $250,000 worth of shares (171,233 units at $1.46) and was granted 400,000 shares, increasing direct ownership by 1,987% to 599,985 units (SEC Form 4)

    4 - Eightco Holdings Inc. (0001892492) (Issuer)

    9/11/25 8:07:01 AM ET
    $OCTO

    Director Jennings Frank D bought $200,000 worth of shares (136,986 units at $1.46), increasing direct ownership by 796% to 154,189 units (SEC Form 4)

    4 - Eightco Holdings Inc. (0001892492) (Issuer)

    9/10/25 3:59:46 PM ET
    $OCTO

    Director Caiano Nicola Paul was granted 2,960 shares and bought $500,000 worth of shares (342,466 units at $1.46), increasing direct ownership by 7,105% to 350,288 units (SEC Form 4)

    4 - Eightco Holdings Inc. (0001892492) (Issuer)

    9/10/25 3:58:39 PM ET
    $OCTO

    $ADVM
    $APVO
    $ASML
    $ASST
    SEC Filings

    View All

    SEC Form S-1 filed by Silo Pharma Inc.

    S-1 - Silo Pharma, Inc. (0001514183) (Filer)

    10/28/25 6:32:49 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    SEC Form 10-Q filed by Bloom Energy Corporation

    10-Q - Bloom Energy Corp (0001664703) (Filer)

    10/28/25 5:21:16 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    SEC Form 425 filed by Strive Inc.

    425 - Strive, Inc. (0001920406) (Filed by)

    10/28/25 4:55:50 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cialone Anthony M. converted options into 1,125,570 shares, increasing direct ownership by 1,060% to 1,231,791 units (SEC Form 4)

    4 - Safe & Green Development Corp (0001959023) (Issuer)

    10/22/25 4:24:40 PM ET
    $SGD
    Real Estate
    Finance

    Director Burnham James D converted options into 1,151,346 shares, increasing direct ownership by 1,215% to 1,246,110 units (SEC Form 4)

    4 - Safe & Green Development Corp (0001959023) (Issuer)

    10/22/25 4:24:18 PM ET
    $SGD
    Real Estate
    Finance

    Director Borg Bjarne Erik Siwert converted options into 1,090,002 shares (SEC Form 4)

    4 - Safe & Green Development Corp (0001959023) (Issuer)

    10/22/25 4:23:56 PM ET
    $SGD
    Real Estate
    Finance

    $ADVM
    $APVO
    $ASML
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

    Investment vehicle provides diversified exposure to real-world assets and expected to reduce portfolio volatility Strategic allocation aligns with Silo's objective of generating yield while maintaining a hedge against downside risk New York, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected Alphaledger/Simplify Target 12% Distribution Fund LLC (the "Alphaledger T12 Fund") as a core component of its real-world asset (RWA) investment strategy on the Solana blockchain. This strategic allocation aligns with Silo's approac

    10/29/25 8:25:00 AM ET
    $SILO
    Apparel
    Consumer Discretionary

    Siebert Financial Opens Washington, D.C. Office To Advance Capital Markets And Investment Banking

    MIAMI, NEW YORK and WASHINGTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Siebert Financial Corp. (NASDAQ:SIEB) today announced the opening of a Washington, D.C. office to support its expanding Capital Markets and Investment Banking team. Located at 3000 K Street, N.W., Suite 245, Washington, D.C., the new office will be led by Daniel M. Ondeck, Head of Institutional Sales, who works closely with Siebert's investment bankers on origination and execution across public and private markets, as well as by newly appointed Managing Director, Debt Sales, Brandon Fry. The new location expands Siebert's national footprint and places its team close to policy, regulatory, and industry stakeholders. It align

    10/29/25 8:00:00 AM ET
    $SIEB
    Investment Bankers/Brokers/Service
    Finance

    Bloom Energy Reports Third Quarter 2025 Financial Results

    Fourth straight quarter of quarterly record revenue 2nd consecutive quarter of double-digit non-GAAP profit margin % in services segment Commercial Progress Continuing to Accelerate Bloom Energy Corporation (NYSE:BE) reported today its financial results for the third quarter ended September 30, 2025. The company reported revenue of $519.0 million for the third quarter of 2025. Third Quarter Highlights Revenue of $519.0 million in the third quarter of 2025, an increase of 57.1% compared to $330.4 million in the third quarter of 2024. Product and service revenue of $442.9 million in the third quarter of 2025, an increase of 55.7% compared to $284.5 million in the third quarter

    10/28/25 4:05:00 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    $ADVM
    $APVO
    $ASML
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bloom Energy upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Bloom Energy from Hold to Buy and set a new price target of $150.00

    10/29/25 10:00:28 AM ET
    $BE
    Industrial Machinery/Components
    Energy

    TD Cowen reiterated coverage on Bloom Energy with a new price target

    TD Cowen reiterated coverage of Bloom Energy with a rating of Hold and set a new price target of $105.00 from $65.00 previously

    10/29/25 7:08:36 AM ET
    $BE
    Industrial Machinery/Components
    Energy

    Five Below upgraded by Analyst with a new price target

    Analyst upgraded Five Below from Neutral to Overweight and set a new price target of $186.00

    10/27/25 8:29:57 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADVM
    $APVO
    $ASML
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    ASML appoints next Chief Technology Officer

    ASML appoints next Chief Technology Officer Marco Pieters appointed ASML Chief Technology Officer ASML Supervisory Board intends to reappoint CFO Roger Dassen and COO Frédéric Schneider-Maunoury, and to appoint CTO Marco Pieters to the Board of Management as of the April 2026 AGM VELDHOVEN, The Netherlands, October 9, 2025 – ASML Holding NV (ASML) today announced the appointment of Marco Pieters as Executive Vice President and Chief Technology Officer, reporting to President and Chief Executive Officer, Christophe Fouquet. With over 25 years of experience at ASML, most recently as Executive Vice President for the product area Applications, Pieters has a strong track record in technology l

    10/9/25 2:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    Cineverse Technology Group Launches Matchpoint™ 3.0 with New Features, Brand Identity

    LOS ANGELES, Oct. 6, 2025 /PRNewswire/ -- Cineverse Corp (NASDAQ:CNVS), a next-generation entertainment studio, has today launched Matchpoint™ 3.0, the newest version of the Company's proprietary, state-of-the-art, automated media supply chain platform that is radically changing the way video content is managed and delivered.  This comes with the launch of a new brand identity, seen now at www.matchpoint.tv, updating and modernizing the UI's look-and-feel, making it easier-to-use for customers.  Trusted by top studios and streaming platforms, Matchpoint is leading the evolutio

    10/6/25 1:15:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ADVM
    $APVO
    $ASML
    $ASST
    Financials

    Live finance-specific insights

    View All

    Bloom Energy Reports Third Quarter 2025 Financial Results

    Fourth straight quarter of quarterly record revenue 2nd consecutive quarter of double-digit non-GAAP profit margin % in services segment Commercial Progress Continuing to Accelerate Bloom Energy Corporation (NYSE:BE) reported today its financial results for the third quarter ended September 30, 2025. The company reported revenue of $519.0 million for the third quarter of 2025. Third Quarter Highlights Revenue of $519.0 million in the third quarter of 2025, an increase of 57.1% compared to $330.4 million in the third quarter of 2024. Product and service revenue of $442.9 million in the third quarter of 2025, an increase of 55.7% compared to $284.5 million in the third quarter

    10/28/25 4:05:00 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    CDT Equity Increases Bitcoin Holding

    NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced the acquisition of 9.25648743 Bitcoin ("BTC") for an aggregate purchase price of $1,005,000 (gross of fees), at an average acquisition price of $108,301.75 per BTC. Following this transaction, CDT's total Bitcoin holdings now stand at 17.9090111 BTC. This acquisition marks a continued execution of CDT's cryptocurrency treasury reserve strategy, aimed at diversifying the Company's balance sheet and enhancing long-term shareholder value through the prudent accumulation of digital assets. "CDT remains committed to strategically deploying capita

    10/17/25 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

    Cerus Corporation (NASDAQ:CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company's financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event. A replay will be av

    10/16/25 4:00:00 PM ET
    $CERS
    EDP Services
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by CERo Therapeutics Holdings Inc.

    SC 13G/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:06:55 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:01:41 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care